MDC Ventures (formerly KBS Ventures)
Cambridge, Massachusetts
Firm Location:Cambridge, Massachusetts • Amsterdam, Netherlands • Israel • Germany • Netherlands • United Kingdom • Switzerland • Bonn, Germany
Investor Firms That Co-Invest with MDC Ventures (formerly KBS Ventures)
Cambridge Innovation CapitalJohnson & Johnson InnovationAbbVie VenturesRA Capital ManagementNovartis Venture FundAtlas VentureFyrfly Venture PartnersHatteras Venture PartnersPfizer Venture InvestmentsMP Healthcare Venture ManagementBuff Gold VenturesOmega FundsBioqube VenturesAndera PartnersBGV (BioGeneration Ventures)INKEF CapitalVersant VenturesMPM Capital5am VenturesSeroba Life SciencesEQT Life SciencesSofinnova PartnersHotmailSROneSV Health Investors' Dementia Discovery Fund (DDF)Syncona Limited
MDC Ventures (formerly KBS Ventures) Team
Investors in Cambridge (MA)
Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Semiconductors (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Semiconductors (Seed), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Health IT (Series A), Investors in Impact (Series A), Investors in Health & Hospital Services (Series A), Investors in Semiconductors (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health IT (Series B), Investors in Impact (Series B), Investors in Semiconductors (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Hakan Goker
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Amsterdam (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Nadiya Ishnazarova
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in United Kingdom
Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Therese Liechtenstein
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Switzerland
Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed)
Radhika Ramachandran
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Germany
Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Semiconductors (Series B), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Bonn (Germany)
Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Semiconductors (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Israel
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B)